Rosenberg Matthew Hamilton Astrazeneca PLC Transaction History
Rosenberg Matthew Hamilton
- $382 Million
- Q4 2024
A detailed history of Rosenberg Matthew Hamilton transactions in Astrazeneca PLC stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 1,135 shares of AZN stock, worth $83,513. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,135
Previous 1,540
26.3%
Holding current value
$83,513
Previous $119,000
37.82%
% of portfolio
0.02%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,351Shares Held
489MCall Options Held
5.88MPut Options Held
4.1M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.02 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...